Seong-Soo Park
Fortune : 87 912 $ au 31/05/2026
Fortune : 87 912 $ au 31/05/2026
Seong-Soo Park currently works at Daewoong Pharmaceutical Co., Ltd., as Co-Chief Executive Officer, Director & VP, AEON Biopharma, Inc., as Independent Director from 2024, and In Therapeutics Co. Ltd., as Director.
Mr. Park received his undergraduate degree and graduate degree from Seoul National University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DAEWOONG CO., LTD. 0,01 % | 26/03/2026 | 7 032 ( 0,01 % ) | 87 912 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AEON BIOPHARMA, INC. | Directeur/Membre du Conseil | 12/04/2024 |
| DAEWOONG PHARMACEUTICAL CO., LTD | Directeur Général | 28/03/2024 |
| DAEWOONG CO., LTD. | Directeur/Membre du Conseil | 26/03/2021 |
In Therapeutics
In Therapeutics Packaged SoftwareTechnology Services Operates a drug development platform | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Daewoong Co., Ltd.
Daewoong Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Daewoong Pharmaceutical Co., Ltd.
Daewoong Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
In Therapeutics
In Therapeutics Packaged SoftwareTechnology Services Operates a drug development platform | Technology Services |
AEON Biopharma, Inc.
AEON Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for neurology and gastroenterology markets | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national